Producción de Insulina Humana Recombinante

La biotecnología se encuentra con la fabricación farmacéutica

Pharmaceutical & Drug Manufacturing Global Industrial Scale $35 billion

Descripción general

Recombinant human insulin is produced using genetically engineered Escherichia coli or Saccharomyces cerevisiae that express the human insulin gene. This biotechnological process replaced the previous method of extracting insulin from pig and cow pancreases, providing unlimited supply with reduced immunogenicity. The process involves fermentation, cell lysis, inclusion body solubilization, refolding, enzymatic modification, and multi-step chromatographic purification to produce pharmaceutical-grade insulin.

Proceso químico

E. coli expressing proinsulin genes are fermented in large bioreactors. Inclusion bodies containing proinsulin are isolated, solubilized in urea, and the protein is refolded by controlled oxidation. Trypsin and carboxypeptidase B cleave the C-peptide to yield mature insulin, which is purified by reversed-phase and ion-exchange chromatography.

Proinsulin →[Trypsin + Carboxypeptidase B] Insulin (A-chain + B-chain linked by disulfide bonds) + C-peptide

Materias primas

  • Glucose (C₆H₁₂O₆) — Corn processing (Carbon source for fermentation)
  • Ammonium sulfate ((NH₄)₂SO₄) — Chemical synthesis (Nitrogen source)
  • Trypsin (enzyme) — Recombinant production (C-peptide cleavage)

Productos finales

  • Recombinant human insulin — Diabetes treatment (>98% purity, multiple analog forms)
<path stroke-linecap="round" stroke-linejoin="round" d="M12 9v3.75m-9.303 3.376c-.866 1.5.217 3.374 1.948 3.374h14.71c1.73 0 2.813-1.874 1.948-3.374L13.949 3.378c-.866-1.5-3.032-1.5-3.898 0L2.697 16.126zM12 15.75h.007v.008H12v-.008z" />

Environmental Impact

Fermentation-based production generates biological waste requiring sterilization before disposal. Chromatographic purification consumes significant water and buffer solutions. However, the environmental impact is far less than animal-sourced insulin which required millions of animal pancreases annually.

Consideraciones de seguridad

Innovaciones recientes

Insulin analogs (lispro, glargine, aspart) with modified amino acid sequences provide faster or longer-acting profiles.
Cell-free protein synthesis and oral insulin delivery systems are in advanced development stages.

Más en Pharmaceutical & Drug Manufacturing

Producción de Penicilina G por Fermentación

Global Industrial Scale

Producción Semi-Sintética de Amoxicilina

Global Industrial Scale

Síntesis de Aspirina por Acetilación del Ácido Salicílico

Global Industrial Scale

Síntesis de Clorhidrato de Metformina

Global Industrial Scale

Síntesis de Ibuprofeno — Proceso Verde BHC

Global Industrial Scale

Síntesis de Omeprazol para Inhibidores de la Bomba de Protones

Global Industrial Scale

Síntesis de Paracetamol (Acetaminofén)

Global Industrial Scale

Frequently Asked Questions

What industry uses Producción de Insulina Humana Recombinante?
Producción de Insulina Humana Recombinante is used in the pharmaceutical & drug manufacturing sector at global industrial scale scale.
What process is involved in Producción de Insulina Humana Recombinante?
E. coli expressing proinsulin genes are fermented in large bioreactors. Inclusion bodies containing proinsulin are isolated, solubilized in urea, and the protein is refolded by controlled oxidation. Trypsin and carboxypeptidase B cleave the C-peptide to yield mature insulin, which is purified by rev
What is the economic significance of Producción de Insulina Humana Recombinante?
Producción de Insulina Humana Recombinante has a market value of $35 billion.
What is the environmental impact of Producción de Insulina Humana Recombinante?
Fermentation-based production generates biological waste requiring sterilization before disposal. Chromatographic purification consumes significant water and buffer solutions. However, the environmental impact is far less than animal-sourced insulin which required millions of animal pancreases annua
What raw materials are used in Producción de Insulina Humana Recombinante?
The main raw materials include: Glucose (C₆H₁₂O₆), Ammonium sulfate ((NH₄)₂SO₄), Trypsin (enzyme).